Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px

Product › Details

ACI-24 (AC Immune)

	Next higher product group	Alzheimer vaccine
	Status	2009-04-01 development p2 planned
	Organisation	AC Immune S.A. (Nasdaq: ACIU)

Record changed: 2023-07-10

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x200px

More documents for Alzheimer drug

[1] Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA....
[2] AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne....
[3] Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel....
[4] AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London....
[5] Asceneuron S.A.. (10/6/23). "Press Release: Asceneuron Welcomes Barbara Angehrn Pavik as New CEO as It Gears Up for Next Phase of Growth". Lausanne....
[6] AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne....
[7] Roche. (3/22/23). "Press Release: Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease". Basel....
[8] MorphoSys AG. (11/14/22). "Press Release: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease". Planegg....
[9] Roche. (11/14/22). "Press Release: Roche Provides Update on Phase III GRADUATE Programme Evaluating Gantenerumab in Early Alzheimer’s Disease". Basel....
[10] Exciva GmbH. (10/26/21). "Press Release: Exciva Raises €9 Million in Series A Round Led by Andera Partners". Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)